Institutional Holders (2026 Q2)
221 + investorsExplore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EWTX. Verified SEC 13F-HR filings.
| # | Investor | % of Portfolio | Shares | Mkt Value |
|---|---|---|---|---|
| 1 | Novo Holdings A/S | 12.62% | 5,350,000 | $217.4M |
| 2 | Orbimed Advisors LLC | 11.68% | 15,518,492 | $630.5M |
| 3 | Paradigm Biocapital Advisors LP | 7.77% | 10,215,455 | $415.1M |
| 4 | Tyro Capital Management LLC | 5.59% | 612,965 | $24.9M |
| 5 | Cormorant Asset Management, LP | 5.23% | 2,510,000 | $102.0M |
| 6 | MPM BioImpact LLC | 4.02% | 1,620,780 | $65.9M |
| 7 | KVP Capital Advisors, LP | 3.97% | 133,000 | $5.4M |
| 8 | Squadron Capital Management LLC | 3.66% | 290,000 | $11.8M |
| 9 | Integral Health Asset Management, LLC | 3.21% | 2,000,000 | $81.3M |
| 10 | Braidwell LP | 3.00% | 1,996,965 | $81.1M |
| 11 | Ally Bridge Group (NY) LLC | 2.99% | 83,300 | $3.4M |
| 12 | Ra Capital Management, L.P. | 2.96% | 8,392,730 | $341.0M |
| 13 | First Light Asset Management, LLC | 2.70% | 1,095,171 | $44.5M |
| 14 | Perceptive Advisors LLC | 2.67% | 4,373,974 | $177.7M |
| 15 | Siren, L.L.C. | 2.62% | 3,184,629 | $129.4M |
| 16 | Parkman Healthcare Partners LLC | 2.40% | 577,036 | $23.4M |
| 17 | Opaleye Management Inc. | 1.84% | 500,000 | $20.3M |
| 18 | Lion Point Capital, LP | 1.77% | 9,100 | $370K |
| 19 | DAFNA Capital Management LLC | 1.76% | 226,819 | $9.2M |
| 20 | Diadema Partners LP | 1.40% | 272,214 | $11.1M |
| 21 | Quantum Private Wealth, LLC | 1.18% | 113,380 | $4.6M |
| 22 | Driehaus Capital Management LLC | 1.11% | 4,728,623 | $192.1M |
| 23 | Verdad Advisers, LP | 1.06% | 27,234 | $1.1M |
| 24 | HighVista Strategies LLC | 0.84% | 90,996 | $3.7M |
| 25 | Persistent Asset Partners Ltd | 0.84% | 69,441 | $2.8M |
| Investor | Ownership History |
% of Portfolio | Prev % | Rank | Conviction | Avg Buy Price | 13F Score™ 3Y / 7Y | Sell Timing | Shares | Mkt Value | Change | Change % | Source | Quarter | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|